Fmr Llc

13F Holdings History for 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Symbol: TXG on Nasdaq
Investment type: Equity / Class A common stock, par value $0.00001 per share
Latest Disclosed Ownership: 9.28M shares
Security Ownership: 8.1%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in 10x Genomics, Inc. Class A common stock, par value $0.00001 per share (TXG)

2025-11-05 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.28M shares of 10x Genomics, Inc. Class A common stock, par value $0.00001 per share (TXG). This represents 8.1% percent ownership of the company. In their previous filing dated 2025-08-07, FMR LLC had reported owning 11.5M shares, indicating a decrease of -19.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	8.1%	-22%	$109M	9.28M	-2,246,033	-19.5%	$11.69	13G/A	9/30/2025	5 Nov 2025 11:17:43
FMR LLC	10.3%	+16.7%	$109M	11.5M	+1,690,630	+17.2%	$9.49	13G/A	7/31/2025	7 Aug 2025 10:06:54
FMR LLC	8.8%	+72%	$93.4M	9.84M	+4,191,183	+74.2%	$9.49	13G/A	6/30/2025	6 Aug 2025 11:44:04
FMR LLC	5.2%	-60%	$43.5M	5.65M	-9,035,879	-61.5%	$7.70	13G/A	4/30/2025	7 May 2025 10:55:48
FMR LLC	13%		$113M	14.7M			$7.70	13G/A	3/31/2025	7 May 2025 10:40:41

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	0%	$98.9M	8.46M	-538,403	-5.98%	$11.69	Q3 2025
6/30/2025	0.01%	0%	$104M	9M	-896,735	-9.06%	$11.58	Q2 2025
3/31/2025	0.01%	0%	$86.4M	9.89M	-3,561,295		$8.73	Q1 2025
12/31/2024	0.01%	+0%	$193M	13.5M	+86,455	+0.65%	$14.36	Q4 2024
9/30/2024	0.02%	+0%	$302M	13.4M	+357,470	+2.75%	$22.58	Q3 2024
6/30/2024	0.02%	+0%	$253M	13M	+81,260	+0.63%	$19.45	Q2 2024
3/31/2024	0.03%	+0%	$485M	12.9M	+143,713	+1.12%	$37.53	Q1 2024
12/31/2023	0.05%	+0%	$715M	12.8M	+118,538	+0.94%	$55.96	Q4 2023
9/30/2023	0.05%	+0.02%	$523M	12.7M	+4,565,400	+56.4%	$41.25	Q3 2023
6/30/2023	0.04%	+0.02%	$452M	8.1M	+3,729,304	+85.3%	$55.84	Q2 2023
3/31/2023	0.02%	+0.01%	$244M	4.37M	+1,169,928	+36.5%	$55.79	Q1 2023
12/31/2022	0.01%	0%	$117M	3.2M	-509,836	-13.7%	$36.44	Q4 2022
9/30/2022	0.01%	-0.01%	$106M	3.71M	-2,483,325	-40.1%	$28.48	Q3 2022
6/30/2022	0.03%	+0.01%	$280M	6.2M	+2,070,318	+50.2%	$45.25	Q2 2022
3/31/2022	0.03%	-0.02%	$314M	4.13M	-3,062,863	-42.6%	$76.07	Q1 2022
12/31/2021	0.08%	-0.01%	$1.07B	7.19M	-1,177,765	-14.1%	$148.96	Q4 2021
9/30/2021	0.1%	+0.01%	$1.22B	8.37M	+467,613	+5.92%	$145.58	Q3 2021
6/30/2021	0.12%	-0.03%	$1.55B	7.9M	-1,843,939	-18.9%	$195.82	Q2 2021
3/31/2021	0.15%	-0.01%	$1.76B	9.74M	-328,920	-3.27%	$181.00	Q1 2021
12/31/2020	0.13%	+0.02%	$1.43B	10.1M	+1,484,389	+17.3%	$141.60	Q4 2020
9/30/2020	0.11%	+0.02%	$1.07B	8.59M	+1,398,273	+19.5%	$124.68	Q3 2020
6/30/2020	0.07%	+0.04%	$642M	7.19M	+3,996,052	+125%	$89.31	Q2 2020
3/31/2020	0.03%	+0%	$199M	3.19M	+57,291	+1.83%	$62.32	Q1 2020
12/31/2019	0.03%	+0%	$239M	3.14M	+385,217	+14%	$76.25	Q4 2019
9/30/2019	0.02%	+0.02%	$139M	2.75M	+2,749,861	NEW	$50.40	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.